Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference43 articles.
1. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group;Roth;J Clin Oncol,1992
2. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study;Wolff;J Clin Oncol,1995
3. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up;Johnson;Ann Intern Med,1985
4. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for ‘limited’ stage small cell carcinoma of the bronchus;Thatcher;Br J Cancer,1989
5. Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer;Shevlin;Lung Cancer,1998
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Benefits of surgery in the multimodality treatment of stage IIB-IIIC small cell lung cancer;Journal of Cancer;2019
2. Treatment of Extensive-Stage Small Cell Lung Cancer;IASLC Thoracic Oncology;2018
3. Tumours of the lung and mediastinum;Cancer and its Management;2014-10-03
4. Small Cell Lung Cancer;60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center;2012-10-26
5. Chemoradiotherapy in limited-disease small-cell lung cancer;Lung Cancer Management;2012-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3